Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22692805 | 1.00 | NPC1 (0.40) | NPC1CA1CA2 | |
| SCHEMBL4426666 | 0.97 | NPC1 (0.37) | NPC1 | |
| SCHEMBL2647631 | 0.82 | ALDH1A1 (0.44) | — | |
| SCHEMBL2647634 | 0.82 | ALDH1A1 (0.44) | — | |
| SCHEMBL8077432 | 0.81 | — | — | |
| SCHEMBL22692804 | 0.79 | NPC1 (0.41) | NPC1 | |
| SCHEMBL21621739 | 0.78 | CTSL (0.33) | — | |
| SCHEMBL24339629 | 0.76 | TSHR (0.31) | — | |
| SCHEMBL10337190 | 0.76 | — | — | |
| SCHEMBL408304 | 0.76 | HTR2C (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2699553-B1 | SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | SIGNAL PHARM LLC (US) | 2023-11-08 | — | — | EP | disclosed |
| EP-3849968-B1 | 1H-INDAZOLE CARBOXAMIDES AS RECEPTOR-INTERACTING PROTEIN KINASE 1 INHIBITORS (RIPK1) | BRISTOL MYERS SQUIBB CO (US) | 2022-12-21 | — | — | EP | disclosed |
| US-20140121243-A1 | NOVEL 1-SUBSTITUTED INDAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2014-05-01 | — | — | US | disclosed |
| EP-1425318-B1 | ACTIVATING ORGANOMETALLIC COMPOSITION FOR THE (CO)POLYMERIZATION OF ALPHA-OLEFINS COMPRISING FLUORINATED CYCLOPENTADIENYL COMPOUNDS | VERSALIS SPA (IT) | 2013-01-16 | — | — | EP | disclosed |
| US-7081505-B2 | Activating organometallic composition for the (co) polymerization of alpha-olefins comprising fluorinated cyclopentadienyl compounds | POLIMERI EUROPA S.P.A. (IT) | 2006-07-25 | — | — | US | disclosed |
| EP-0771822-B1 | Catalytic system for the (co)polymerization of alpha-olefins | POLIMERI EUROPA SPA (IT) | 2005-04-13 | — | — | EP | disclosed |
| US-20040198934-A1 | Activating organometallic composition for the (co) polymerization of alpha-olefins comprising fluorinated cyclopentadienyl compounds | POLIMERI EUROPA S.P.A. (IT) | 2004-10-07 | — | — | US | disclosed |
| EP-1425318-A1 | ACTIVATING ORGANOMETALLIC COMPOSITION FOR THE (CO)POLYMERIZATION OF ALPHA-OLEFINS COMPRISING FLUORINATED CYCLOPENTADIENYL COMPOUNDS | Polimeri Europa S.p.A. (IT) | 2004-06-09 | — | — | EP | disclosed |
| WO-2003010210-A1 | ACTIVATING ORGANOMETALLIC COMPOSITION FOR THE (CO)POLYMERIZATION OF ALPHA-OLEFINS COMPRISING FLUORINATED CYCLOPENTADIENYL COMPOUNDS | POLIMERI EUROPA S.P.A. (IT) | 2003-02-06 | — | — | WO | disclosed |
| US-6274529-B1 | COORDINATION CATALYST CONTAINS METALLOCENE OF HAFNIUM, TITANIUM, OR ZIRCONIUM, AND HETEROCOMPOUND CONTAINING OXYGEN, NITROGEN, SULFUR, AND/OR PHOSPHORUS | ENICHEM S.P.A. (IT) | 2001-08-14 | — | — | US | disclosed |
| EP-0771822-A1 | Catalytic system for the (co)polymerization of alpha-olefins | ENICHEM S.p.A. (IT) | 1997-05-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140121243-A1 | NOVEL 1-SUBSTITUTED INDAZOLE DERIVATIVE | CHRNA3, CHRNB3, CHRNA7 | NPC1 2458/4885CA1 1836/4885CA2 1501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.